Partnership between CDI-Negev and Strategic Interests accelerates U.S. market penetration for Israeli health it start-ups

Pilots in Rochester and Johns Hopkins laying foundation for success

FEBRUARY 14, 2017, Rochester, NY  & Tel Aviv, Israel CDI-Negev, the Center for Digital Innovation, an Israel-based innovation center dedicated to supporting entrepreneurs develop health-related technologies and Strategic Interests, LLC (SI), a Rochester-NY based consulting firm helping stakeholders collaborate, improve care and enhance financial performance, teamed up to help several innovative Israeli healthcare IT start-up companies bring their solutions to the U.S.

“Strategic Interests is pleased to work with CDI-Negev to help their members determine the most appropriate segments for their solutions, find opportunities to demonstrate value with U.S. providers and payers, and develop and execute segment-specific market attack plans to succeed in the dynamic and growing U.S. healthcare marketplace” said Al Kinel, President of SI.

Ambassador Ido Aharoni, Global Distinguished Professor at NYU and Former Consul General of Israel in New York, played a key role in linking CDI with SI. “While the U.S. healthcare market is attractive to Israeli start-ups, it’s difficult to avoid costly missteps while navigating the complex environment,” stated Aharoni. “A partner such as SI can leverage experience and long-standing relationships to help Israeli health tech companies succeed here in the U.S.  Al and I share the same desire to help accelerate one of Israel’s most precious exports and it’s exciting to see how he is bringing this to fruition.”

Transforming caregivers’ ability to remotely monitor patients suffering from chronic health conditions, SI connected Datos Health, a CDI mhealth company, with Rochester, NY-based Ridgeview Internal Medicine Group, LLP.  In Datos’ first U.S. pilot, Ridgeview’s primary care physicians and care managers are remotely monitoring patients suffering from hypertension. The Datos platform enables caregivers access to clean, validated, Patient-Generated Health Data (PGHD) for use within their electronic medical record (EMR) and existing workflow, for improved disease management and outcomes, at a fraction of the current cost.  The U.S project follows multiple pilot programs run by Datos monitoring diabetes and high blood pressure within long-term and post-acute care organizations in Israel.

To make the road to recovery more efficient, cost effective, and fun, Israel-based BG Ventures developed the BioGaming Artificial Intelligence-based platform to help patients accurately perform rehabilitation exercises using virtual trainers and games while monitoring their progress with pinpoint precision. Founded in 2016, BioGaming has been categorized as an FDA-approved medical device and is demonstrating success with users in US, Israel and Latin America, where a project at Johns Hopkins is proving current benefits and future promise.

“Process automation, in-clinic utilization and increasing adherence are the main goals in the world of physical therapy today” said Ken Johnson, Director, Rehabilitation Therapy Services Outreach of Johns Hopkins. “BioGaming’s platform digitizes physical therapy. By providing automatic assessments, an in-clinic virtual trainer application and a mobile app to easily manage and monitor patients’ process, BioGaming achieves efficient resource allocation for physical therapy clinics—reducing costs for clinics, providers and payers.”

“Each of our young companies has unique capabilities and needs,” stated Ziv Ofek, Founder and CEO of CDI and Founder of dbMotion. “Working with SI during the past 8 years, I am keenly aware of the depth and breadth of experience that Al’s team possesses to properly support our member companies on the road to commercial success—they are in good hands with SI.”

Additional CDI companies looking to SI for U.S. traction in 2017

As leaders in data science and artificial intelligence (AI), Israel’s most promising digital health startups provide real value in the existing clinical workflow through the introduction of new and more effective capabilities to increase accuracy and improve quality outcomes in less time. Here are a few companies to watch in 2017:

  • Aidoc helps radiologists analyze imaging and clinical data more effectively to produce highly accurate scan anomaly detection.
  • DiACardio provides FDA-cleared tools that fully automate the evaluation of medical imaging using a new image processing technology based on pattern recognition and machine learning.
  • Healthy.io uses computer vision and artificial intelligence to turn embedded smartphone cameras into clinical grade medical devices and bring digitized core diagnostic tests from the lab into the hands of patients.
  • Mediseen (A subsidiary of Teva Pharmaceutical Industries Ltd.) Developed DDI+, a cloud-based patient-specific decision support system for managing patient’s Drug Related Problems (DRP).
  • Ziv Ofek’s startup, MDClone, introduces a new healthcare data paradigm with a big data platform unlike anything on the market today, unleashing the power of healthcare data for analysis with zero-risk to patient privacy.

 

About CDI-Negev:  

CDI-Negev is a leading-edge, novel, non-profit innovation center located in Beer-Sheba, Israel— the growing ‘Silicon Valley’ of the Middle East. CDI works in the areas of digital healthcare, social welfare, with a focus on healthy aging, education and smart cities. In partnership with Ben-Gurion University, CDI brings together start-up companies, experienced entrepreneurs, innovators, researchers in the public sector and investors with a personalized support system and a dedicated network of industry thought leaders committed to overcoming barriers for global success.

Visit www.cdi-negev.com for more information.

For PR & Media Inquiries: Lital Shnaiderman | lital@cdi-negev.com  | +972 (58) 621-7014

About Strategic Interests:

Strategic Interests (SI) offers advisory and implementation services to help healthcare stakeholders collaborate, improve care and enhance financial performance. As trusted experts in transformation, SI combines vision, deep technological understanding and innovative thinking to each customized, pragmatic client engagement. Using our proven framework, our team of results-oriented, experienced thought-leaders—each with years of experience in various areas of healthcare including management, clinical, analytical, technical, and marketing—delivers on the specific needs of each project, ensuring our clients’ objectives are met and their expectations are exceeded.

Visit www.strategicinterests.com for more information.

For PR & Media Inquiries:  Kate Kolbrener | kkolbrener@strategicinterests.com | 412-310-0617